Simplifying Global Compliance
Ben Venue Laboratories, Inc. - May 25, 2011
There is a lack of adequate oversight by the Quality Unit to approve or reject the products manufactured and processed, as well as approve or reject the established procedures and/or specifications impacting the quality of the drug product.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing